The 57th American Society for Mass Spectrometry (ASMS) meeting was held in Philadelphia, Pennsylvania, from May 31 though June 4. Despite the recession, attendance only declined slightly to 6,542, down from 6,569 in 2008 (see IBO 6/15/08). The number of exhibitors contracted for the second year in a row, declining to 165 from 171 in […]
Although German GDP fell 6.7% in the first quarter on an annual basis, one would not have suspected it from the convention floor at ACHEMA 2009, which took place from May 11 to 15 in Frankfurt am Main. The various halls that compose the Messe Frankfurt exhibition grounds thronged with visitors and exhibitors. Total attendance […]
In what a number of publicly traded analytical instrument companies called their toughest quarter ever, the first quarter of calendar-year 2009 was a challenging environment for sales of analytical and laboratory instruments and even, in some cases, laboratory consumables. Revenues in reported currencies for 10 of the 11 companies profiled on pages 9–11 declined during […]
For the third consecutive month, the markets closed in positive territory, as the Dow Jones Industrial Average, S&P 500 and NASDAQ climbed 4.1%, 5.3% and 3.3%, respectively. Despite the major US stock indexes trading within a narrow range for most of May, investors turned bullish during the final two trading days of the month due […]
The crystal ball is very cloudy, according to the results of IBO’s Spring 2009 Business Climate Survey. Twice a year, IBO surveys executives at analytical and life science instrument and laboratory product companies to gage their expectations for business conditions in the short term, and to gain their opinions on current issues affecting the market. […]
First-quarter revenues for IBO’s Laboratory Instrument Sales Index declined 2.4% to $4,863 million. Operating profit improved 2.0% to $849 million, and operating margin climbed 80 basis points to 17.5% of sales. Revenues were adversely affected by the economic slowdown and, for US firms, by the higher valuation of the US dollar. A majority of companies […]
In fiscal 2008, average short-term and long-term compensation for 56 executives at 44 analytical instrument and laboratory product companies in IBO’s three Stock Indexes (see IBO 4/30/09) increased, according to the latest results of IBO’s annual Executive Compensation Survey. Average total short-term compensation grew 5.1% to $1,199,310, while average total long-term compensation rose 13.2% to […]
Field flow fractionation (FFF) has existed for more than 40 years and is primarily used for the separation and characterization of large particles; however, it has not reached the popularity of other separation techniques for this application. FFF works much like LC, but uses a thin flow channel instead of a column. In place of […]
Appeals US federal appeals courts have ruled on two long running patent infringement cases involving Applied Biosystems and Waters. Last fall, the US District Court of Appeals for the Federal Circuit ruled on appeals brought by Cohesive Technologies (now Thermo Fisher Scientific) and Waters related to Cohesive’s 1998 suit against Waters (see IBO 12/15/98). In […]
In April, all major US stock indexes climbed higher despite weak economic data and mixed first-quarter earnings. The Dow Jones Industrial Average, S&P 500 and NASDAQ finished the month up 7.3%, 9.4% and 12.3%, respectively. The markets shrugged off higher than expected unemployment claims, increasing foreclosure rates and the report of a 6.1% annual decline […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
